PCSK9-IN-10
Product Specifications
CAS Number
368434-98-4
Target
Serine/threonin kinase, LDLR, Others
Related Pathways
Cell Cycle/Checkpoint, Others, Metabolism
Purity
0.9906
Bioactivity
PCSK9-IN-10, a potent and orally active inhibitor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), exhibits a half-maximal inhibitory concentration (IC50) of 6.4 μM. By enhancing the expression of Low-Density Lipoprotein Receptor (LDLR) protein and reducing PCSK9 expression, PCSK9-IN-10 effectively decreases atherosclerosis progression. This compound holds promise for hyperlipidemia research applications.
Smiles
COCCNc1nc2n(C)c(=O)n(C)c(=O)c2n1Cc1cccc(OC)c1
Molecular Formula
C18H23N5O4
Molecular Weight
373.41
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
134393-HRP 100 µL
TGM1 (Transglutaminase-1, TGase-1, Protein-glutamine gamma-glutamyltransferase K, Epidermal TGase, KTG, Transglutaminase K, TGase K, TG (K), TGK) (HRP)
Sign In for Pricing
View Details 
orb2919561-01 20 µg
Recombinant Yersinia pestis bv. Antiqua Probable intracellular septation protein A (YpAngola_A2326)
Sign In for Pricing
View Details orb2919561-02 100 µg
Recombinant Yersinia pestis bv. Antiqua Probable intracellular septation protein A (YpAngola_A2326)
Sign In for Pricing
View Details GTR15166242 1 Vial
Lentiviral mouse Shprh shRNA (UAS) - Lentiviral mouse Shprh shRNA (UAS) (100)
Sign In for Pricing
View Details